Join us at the European Heart House in Nice for the RESILIENCE multi-stakeholder event: Survive cancer with a strong heart
The European Society of Cardiology (ESC) through the ESC Council of Cardio-Oncology will host on October 19th the first multi-stakeholder meeting in the context theRESILIENCE project, funded by the European Commission, to share the latest resultswith different stakeholders and patients. The event will focus on emerging therapies for cancer therapy induced cardiotoxicityand will gather a wide number of members of the RESILIENCE consortium along with world leaders in the field of […]
Science and Innovation Week
On Thursday, November 16th at 19:00 hours we will organize the “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” within the activities held in Madrid on the occasion of the Science and Innovation Week. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” will consist of a free activity, for the public of all ages, […]
RESILIENCE participates in the European Researchers Night in Madrid
RESILIENCE Project will participate on Friday, September 29th in the XIV European Researchers Night in Madrid with an activity in which the public of all ages can attend, free of charge, with prior registration. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” where we will have the opportunity of getting closer […]
RESILIENCE broadens the spectrum of patients who may benefit from entering the trial
The RESILIENCE trial has expanded its inclusion criteria to allow more types of lymphoma to be included in the trial. These changes are proposed after having agreed with the recruiting hospitals. To date, only patients with a specific type of lymphoma (non-Hodgkin) were included, but after a careful study by the research team, it has […]
Remote Ischemic Conditioning for Anthracycline Cardiotoxicity: The Need to Protect the Most Vulnerable
This article is authored by 2 PIs of RESILIENCE (María Gomes-Silva from IPO Lisbon & Borja Ibanez from CNIC Spain). This editorial summarizes the results of the 2 first trials testing remote ischemic conditioning in the context of anthracycline cardiotoxicity. In this article, the 2 trials are described and their results put into perspective of […]
Initial visit at the San Carlos Clinical Hospital
On Friday June 16th we made the initial visit at the San Carlos Clinical Hospital in Madrid and it is with great pleasure that we welcome this Hospital to our RESILIENCE project, in which we work hard every day to help people survive cancer with a strong heart. During the visit we met with the […]
Hospital 12 de Octubre joins RESILIENCE
On Thursday June 1st Hospital Universitario 12 de Octubre in Madrid has joined the RESILIENCE project and it will most probably begin to recruit patients in the coming weeks. Hospital 12 de Octubre obtained in 2020 the Best in Class (BIC) Award for the Best Service in Hematology and Hemotherapy, the BIC for the Best Service […]
RESILIENCE Steering Committee and General Assembly session
On Friday May 12th our RESILIENCE Steering Committee and General Assembly session were held at the National Center for Cardiovascular Research (CNIC) in Madrid. The meetings counted on the support of all the partners of the project financed by the European Commission, both national and international, as well as members of the external scientific advisory […]
Gregorio Marañón Hospital joins RESILIENCE
It is a great satisfaction for us to inform you that on Monday April 17th Hospital General Universitario Gregorio Marañón in Madrid has joined the RESILIENCE project. The Hospital will begin to recruit patients in the coming weeks with the aim of strengthening the hearts of people undergoing cancer treatment with anthracyclines. At the Hospital […]
Virgen de las Nieves University Hospital joins RESILIENCE
RESILIENCE grows every day with the incorporation of new centers that expand the network of influence of our project, whose objective is to help people undergoing cancer treatment with anthracyclines to continue their lives with a strong heart. The latest addition has been the Hospital Universitario Virgen de las Nieves in Granada, with whom we […]
